Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin in Metastatic Urothelial Cancer
NCT00004203Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Feb 2000
- Primary completion
- Feb 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of oxaliplatin in urothelial carcinoma (UC), sponsored by University of Chicago. Started Feb 2000; status: completed.
02
Drugs
oxaliplatin
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00004203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004203.